Provided by Tiger Trade Technology Pte. Ltd.

Ionis Pharmaceuticals

51.44
-2.7700-5.11%
Pre-market: 51.840.4000+0.78%09:12 EDT
Volume:5.97M
Turnover:312.34M
Market Cap:8.55B
PE:-14.78
High:55.50
Open:54.88
Low:51.31
Close:54.21
52wk High:86.74
52wk Low:50.01
Shares:166.18M
Float Shares:161.92M
Volume Ratio:1.48
T/O Rate:3.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4800
EPS(LYR):-2.3812
ROE:-105.50%
ROA:-12.42%
PB:19.44
PE(LYR):-21.60

Loading ...

Aug 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jul 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2025

Major Issues Report

Form 8-K - Current report
Jun 12, 2025

Major Issues Report

Form 8-K - Current report
Jun 10, 2025

Major Issues Report

Form 8-K - Current report
May 19, 2025

Major Issues Report

Form 8-K - Current report
Apr 30, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 30, 2025

Major Issues Report

Form 8-K - Current report
Apr 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 12, 2025

Major Issues Report

Form 8-K - Current report
Mar 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 20, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 19, 2025

Major Issues Report

Form 8-K - Current report
Feb 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 31, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities